ENTITY
Opthea Ltd

Opthea Ltd (OPT AU)

33
Analysis
Health CareAustralia
Opthea Limited is a biologics drug developer for ophthalmic diseases. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
more
bullishTuas Ltd
08 Sep 2025 05:00

S&P/​​​​ASX Index Rebalance (Sep 2025): New Methodology & The Many Changes

There are 53 stocks that are adds/deletes across the ASX family of indices. There are some surprises and big flow/impact across the changes. Adds...

Logo
779 Views
Share
bullishDroneShield Ltd
25 Aug 2025 06:04

S&P/​​​​​​​​​ASX Index Rebalance Preview (Sep 25): Potential Changes if Methodology Is Updated

The review period for the September rebalance is done and the proposals in the market consultation will be implemented. That means a lot of change...

Logo
1.6k Views
Share
bullishGQG Partners
31 Jul 2025 05:40

S&P/ASX Indices: Proposed Methodology Changes & The BIG September Rebalance

The market consultation ends in 2 weeks, and the conclusions should be announced soon after that. A lot of the stocks have moved significantly over...

Logo
1.4k Views
Share
bullishRegal Partners
29 Jul 2025 13:00Syndicated

Regal Partners Recovers Performance Fee Mojo

Auguring well for upcoming interim results, Regal Partners has provided a positive quarterly update showing a rebound for funds under management...

Logo
FNArena
219 Views
Share
03 Jul 2025 16:29

ASX Short Interest Weekly (Jun 27th): National Australia Bank, Cochlear, Northern Star Resources

We analyzed ASX short interest report for the past week and highlight short interest changes in National Australia Bank, Cochlear, Northern Star...

Logo
388 Views
Share
x